Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Radiation × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 6 Oropharyngeal Neoplasms 5 Glioblastoma 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Glioma 3 Carcinoma 3 Astrocytoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Hypopharyngeal Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Ependymoma 2 Burkitt Lymphoma 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Sinonasal undifferentiated carcinoma 1

Interventions

Rituximab 15 CT-P10 6 ibrutinib 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 zanubrutinib 4 venetoclax 4 pirtobrutinib 4 glofitamab 4 fludarabine 4 Lenalidomide 4 acalabrutinib 3 Specimen Handling 3 Bendamustine Hydrochloride 3 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Cytarabine 2 Cyclosporine 2 Biopsy 2 voruciclib 1 treosulfan 1 tislelizumab 1 palbociclib 1 ixazomib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Watchful Waiting 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡